Speaker Profile
M.D., Executive Vice President and Chief Technology Officer, Amgen
Biography
David Reese oversees Amgen's Digital and Technology Innovation, the Office of the Chief Medical Officer, and the development and deployment of artificial intelligence across the enterprise. Reese joined Amgen in 2005 and previously served in various leadership roles within the Research and Development organization. This includes most recently functioning as executive vice president of Research and Development, where he oversaw Amgens worldwide research efforts and the advancement of Amgens pipeline in all therapeutic areas.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
- William Oh, Mount Sinai
Patient-centric data, such as Real-World Evidence (RWE) and Real-World Data (RWD), has become critical in reshaping drug development and healthcare decision-making. Over the last few years, regulatory agencies like the FDA and EMA have increasingly embraced RWE/RWD for decision-making processes, influencing everything from new drug indications to post-marketing surveillance. The integration of RWE and RWD is not only supporting clinical trial design and regulatory approvals, but also enabling precision medicine by providing deeper insights into patient subpopulations and their outcomes
Sessions:
- PMWC 2025 Award Ceremony
Pioneer Honoree: Isaac Kohane, Harvard
- Keynote: Can AI succeed where humans have failed to personalize medicine?
- Isaac Kohane, Harvard
- From Data to Decisions: Real-Time Patient Insights for Improved Care (PANEL)
Chair: Michael Pfeffer, Stanford Medicine
- Chris Longhurst, UC San Diego Health
- Tanya Townsend, Stanford Children’s
- Kiran Mysore, Sutter Health
- Cherodeep Goswami, UW Health - AI-Powered RWE: Driving Trustworthy Insights and Innovation through Interoperability (PANEL)
Chair: Charles Jaffe, HL7 International
- Data Privacy and Security (and Health Equity) Challenges to the Use of Health Data in AI (PANEL)
Chair: Deven McGraw, Invitae
- Bakul Patel, Google - Accelerating Drug Development with Real World Evidence and AI: Amgen's Journey
- David M. Reese, Amgen
